SKB565 for Injection in Advanced Solid Tumors

Summary

This is a phase I/II clinical study to evaluate the safety and efficacy of SKB565 in participants with advanced solid tumors. The study includes a dose escalation stage, a dose expansion stage, and a indication expansion stage.

Timeline

Start

2026-06

Primary completion

2028-12

Completion

2029-05

Drugs

Indications